Genecards® Create Exciting New Link Between Human Genes and Chemical Reagents from Tocris Bioscience
News Oct 01, 2008
Dr Robert Felix, Tocris’ Product Manager said, “The new ability provided by GeneCards to rapidly associate Tocris’ high quality research compounds with genes and proteins highlights the central importance of chemical tools in the study of the biology of our genes. We expect that this capability will be of great benefit to life scientists and will lead to new avenues of research.”
The powerful GeneCards search engine provides users with concise genomic, proteomic, transcriptomic, genetic and functional information on all known and predicted human genes.
Information featured in GeneCards includes orthologies, disease relationships, mutations and SNPs, gene expression patterns, gene function, pathways, protein-protein interactions, related drugs and compounds, and direct links to Tocris’ comprehensive 'Target files'
A recent introduction to the Tocris website, ‘Target Files’ consist of a concise summary of the biological target, together with links to external sources of genetic and pharmacological information. Tocris products with activity at each target are listed here allowing rapid identification of the most relevant research tools.
Dr. David Warshawsky, Chief Executive Officer of Xennex Inc., the commercial partner of GeneCards, added “We are very pleased about our work with Tocris and are delighted that GeneCards users will have gene-specific access to Tocris’ high quality research compounds. I am confident that offering access to Tocris’ products will help many of our users in academia and industry in their efforts in areas such as basic research and drug discovery.”
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE